Login
$BBIO
$77.40 -$0.90 (1.15%) Live

$BBIO SEC Filings

Filed On Filing
12 Nov 2026 SCHEDULE 13G/A
03 Nov 2026 Form 4: Apuli Maricel, Chief Accounting Officer

Sold 2,000 shares ($146K)

29 Oct 2026 10-Q
29 Oct 2026 8-K: Results of Operations and Financial Condition

- $353.2 million in total third quarter revenues, primarily comprised of $253.2 million of U.S. Attruby net product revenue (up approximately $31 million sequentially and $145 million year over year). Loss from operations was $11.6 milli...

27 Oct 2026 SCHEDULE 13G
13 Oct 2026 8-K: Other Events

- Accepted for Priority Review with a PDUFA target action date of February 4, 2027; being granted Priority Review by the FDA underscores the significant unmet need for an oral targeted therapeutic option for children with achondroplasia

21 Sep 2026 Form 4: Kumar Neil, Director

Sold 10,000 shares ($691K)

31 Aug 2026 8-K: Other Events

BridgeBio Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans

20 Aug 2026 Form 4: Kumar Neil, Director

Sold 34,980 shares ($2.89M) · Sold 10,000 shares ($840K)

19 Aug 2026 144
18 Aug 2026 Form 4: Trimarchi Thomas, President and CFO

Gave up 22,781 shares to cover exercise price or tax ($1.82M)

18 Aug 2026 Form 4: Kumar Neil, Director

Received 71,217 shares by exercise or conversion · Gave up 36,237 shares to cover exercise price or tax ($2.89M)

18 Aug 2026 Form 4: Apuli Maricel, Chief Accounting Officer

Gave up 4,714 shares to cover exercise price or tax ($376K)

18 Aug 2026 144
17 Aug 2026 SCHEDULE 13D/A
17 Aug 2026 144
17 Aug 2026 8-K: Entry into a Material Definitive Agreement; Other Events

As representatives (the “Representatives”) of the several underwriters

14 Aug 2026 424B7
10 Aug 2026 10-Q
10 Aug 2026 8-K: Results of Operations and Financial Condition

- $243.7 million in total second quarter revenues, primarily comprised of $222.4 million of U.S. Attruby® net product revenue, with growth led by the treatment-naïve segment as physicians increasingly start and keep patients on Attruby

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support